数字治疗性市场份额，规模，趋势，行业分析报告，通过申请（糖尿病，肥胖，CVD，CNS病，呼吸系统疾病，吸烟，其他），通过最终用途（患者，提供者，付款人，雇主，其他），按地区;分部预测，2021 - 2028

报告摘要

2020年全球数字化疗市场的价值为21.18亿美元，预计预测期内的CAGR成长为26.1％。公众越来越意识到了快速发展的数字世界。此外，通过提高慢性疾病患病率和快速技术进步，推动了数字治疗的市场。

了解有关此报告的更多信息：request for sample pages

As a result of the introduction of emerging technology and solutions, end-user awareness is expected to grow, propelling the digital therapeutics industry forward. Consumer attitudes towarddigital healthare expected to continue to change, as will their appetite for affordable, personalized, and engaging medical solutions.

Industry Dynamics

Growth Drivers
数字治疗方法需求的另一个重要技术因素是智能手机的增加和人们之间的互联网使用。印度市场是世界上增长最快的应用市场，根据印度手机和电子协会发表的一份报告，于2020年7月。2019年，该国有5000万智能手机用户，该数字预计将增加到829万升，到2022年。

Covid-19爆发对有关市场产生了积极的影响。易于和经济实惠的数字健康解决方案需求的出现是主要的Covid相关的市场司机。在大流行期间，FDA于4月2020年4月宣布，它将更容易获得和使用数字健康治疗设备进行心理健康问题。

As a result, digital therapeutics providers can commercialize their solutions without having to comply with traditional regulatory standards, as long as the products do not pose an unnecessary risk in light of the public health emergency.

A factor that is anticipated to push the therapeutics market forward is mental wellbeing. The pandemic worsened mental health problems, highlighting the need for new treatment methods. This opens up a lucrative opportunity for digital therapeutics firms.

The U.S., for example, will hold presidential elections in November 2020. The Food & Drug Administration agency has approved Nightware, a digital therapeutics firm, for the temporary reduction of sleep disruption in PTSD patients.

Digital Therapeutics Market Report Scope

该市场主要根据应用，最终用途和地理区域进行分段。

通过申请	通过最终使用	按地区
糖尿病 肥胖 CVD. CNS Disease Respiratory Diseases Smoking Cessation Others	Patients 提供者 Payers 雇主 Others	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

应用洞察力

In 2020, the diabetes market segment dominated the digital therapeutics industry. In the given timeframe, this therapeutics application segment is likely to rise at the fastest rate. Diabetes is becoming more common in the world's population, which is fueling this development. As per the IDF, there were 463 million diabetics in the world in 2019, with 700 million anticipated by 2045.

因此，预计相关数字治疗解决方案的市场需求将增加。例如，患有糖尿病的患者需要仔细治疗，教练和教学，以应对较益脂素，聚需要的症状，以及药物提醒。

Insight by End-Use

In 2020, the patient market segment dominated the digital therapeutics industry, and it is anticipated to attain significant market share over the forecast period. Therapeutic healthcare applications and services are mostly used for patients. The market for digital therapeutics is growing in response to the growing number of patients suffering from chronic illnesses.

Geographic Overview

随着数字治疗的主要市场参与者的存在，日益增长的政府政策，发达的医疗保健系统以及北美的慢性健康问题的普遍性，2020年在2020年举行了最大的份额。betway体育亚洲版入口

美国FDA于2020年4月发表了建议，以增加数字设备的使用进行精神病。该FDA计划支持在Covid-19健康紧急情况下，在没有任何临床内预约的情况下突破家庭检疫订单的人。

亚太数字疗法是预期的to grow at the fastest pace due to two major factors including a large and relatively young demographic audience, which translates into a massive target base, and rapid urbanization and digitization. Furthermore, ongoing reforms in the countries for infrastructure deficits and maintain long-term growth.

According to the India Cellular and Electronics Association's 2020 report, 97.0% of internet users in India use mobile devices to access the internet, owing to factors such as lower smartphone costs, increased mobile data availability, a rise in the number of rural users, and government initiatives.

竞争洞察力

数字治疗产品中的主要市场参与者正在集中精力，以提高他们的研发能力，帮助他们为用户提供创造性解决方案并获得竞争优势。

Market participants such as Proteus Digital Health, Inc., Fitbit, Inc., Pear Therapeutics, Inc., Kaia Health, Happify, Inc., Medtronic Plc., Omada Health, Inc., Livongo Health, Inc., Voluntis, Inc., Resmed, Inc., and Welldoc, Inc. are some of the companies operating in the digital therapeutics market.